randomised trial of the flt3 inhibitor gilteritinib as post-transplant maintenance for flt3-itd aml
Published 1 year ago • 65 plays • Length 2:34Download video MP4
Download video MP3
Similar videos
-
1:33
the use of gilteritinib in post-transplant maintenance for aml with flt3-itd
-
1:59
optimizing the use of flt3 inhibitors in aml: sequencing, post-transplant maintenance & more
-
5:09
morpho: gilteritinib as post-transplant maintenance therapy in patients with flt3-itd aml
-
2:27
gilteritinib maintenance after allogeneic transplantation in flt3-mutated aml
-
2:29
flt3 inhibitors as maintenance therapy in aml
-
2:46
role of flt3 inhibitors as maintenance following transplant in aml
-
4:47
the use of flt3 inhibitors in aml
-
1:06
investigating the molecular and clinical features of flt3-jmd mutations in aml
-
1:35
flt3 inhibitor maintenance after allo-sct for aml
-
0:49
treatment avenues for patients with r/r flt3-mutated aml: optimizing flt3 inhibitors
-
1:03
targeted therapies in newly diagnosed aml: bcl2, flt3 and idh inhibitors
-
1:12
gilteritinib relapse leads to loss of flt3-tkd mutation in patient with aml
-
2:40
an overview of the safety profile of flt3 inhibitors in aml
-
2:27
eha 2022 | harry erba | quizartinib, flt3 inhibitor boosts overall surivival in aml #aml
-
3:27
novel flt3 inhibitors for aml
-
1:12
the value of flt3 inhibitors in aml and focus for future trial designs
-
1:50
progress for gilteritinib and quizartinib for aml in the first-line setting
-
5:04
clinical outcomes of patients with flt3-itd-mutated r/r aml undergoing hsct after quizartinib or...
-
7:01
azacitidine, venetoclax and gilteritinib for patients with flt3-mutated acute myeloid leukaemia